Cell Analysis Market worth $23.0 Billion by 2018
DALLAS, April 14, 2014 /PRNewswire/ --
According to new market research report the "Cell Analysis Market by Instruments (Flow Cytometer, Microscope, Microfluidics, Qpcr), Consumables, Application (Cell Identification, Cell Viability, Cell Proliferation, Cytology, Signal Transduction, Single Cell Analysis) - Global Forecast to 2018" published by MarketsandMarkets, The global Cell Analysis Market was valued at an estimated $16.7 Billion in 2013 and is expected to reach $23.0 Billion by 2018, growing at a CAGR of 6.6% from 2013 to 2018.
Browse 111 Market Data Tables and 9 Figures spread through 220 Pages and in-depth TOC on "Cell Analysis Market"
Early buyers will receive 10% customization on this report.
Enhanced accuracy of cell imaging and analysis systems helps in reducing the time and costs involved in the drug discovery process. This is a major factor driving the growth of the cell analysis market. Furthermore, the market is witnessing significant technological innovations and continuous improvements in cell analysis instruments and consumables for applications such as cell identification, cell proliferation, and target toxicity studies. This is another factor propelling the growth of this market. Corporate and government support for the growth of innovative technologies and rising demand for outsourcing of drug discovery services, especially in the Asia-Pacific region, are also the major reasons for the high-growth of this market. Based on cell analysis products, the consumables market commanded the largest share of 65.5% in 2013. However, the cell analysis instruments market is poised to grow at the highest CAGR from 2013 to 2018.
Based on geography, the global Cell Analysis Market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America accounted for the largest share of the market in 2013. This large share of the North American region can be attributed to the presence of government funding and various collaborations among prominent players for developing and marketing new products in the market.
The major players in the Cell Analysis Market include BD Biosciences (U.S.), Thermo Fisher Scientific (U.S.), Danaher Corporation (U.S.), Sigma-Aldrich Corporation (U.S.), GE Healthcare (U.K.), Olympus (Japan), Agilent Technologies, Inc. (U.S.), PerkinElmer (U.S.), Merck KGaA (Germany), and Promega (U.S).
Browse related reports
High Content Screening Market by Instruments (Cell Imaging and Analysis System), by Applications (Primary and Secondary Screening, Target Identification and Validation, Toxicity Studies, Compound Profiling), Software & Services - Global Forecasts to 2018
Microfluidics Market By Materials (Polymers, Silicon, Glass), Pharmaceuticals (Microreactors, Toxicity Screening, Lab on Chip, Proteomic & Genomic Analysis) Drug Delivery Devices (Microneedles, Micropumps), IVD (POC) - Global Trends & Forecast to 2018
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.
MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals; including advanced materials, automotives and transportation, banking and financial services, biotechnology, healthcare IT, chemicals, consumer goods, telecommunications and IT, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, agriculture industry, semiconductor and electronics, aerospace & defense.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
North - Dominion Plaza
17304 Preston Road
Suite 800, Dallas, TX 75252
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets